BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 17587515)

  • 1. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
    Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
    Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
    Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
    Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
    Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
    Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies.
    Wang JH; Zhao J; Lin J
    J Minim Invasive Gynecol; 2010; 17(1):53-8. PubMed ID: 20129333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical parameters linked with malignancy in endometrial polyps.
    Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
    Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The malignant potential of endometrial polyps.
    Ben-Arie A; Goldchmit C; Laviv Y; Levy R; Caspi B; Huszar M; Dgani R; Hagay Z
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):206-10. PubMed ID: 15262357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of premalignant and malignant pathology in endometrial polyps.
    Bakour SH; Khan KS; Gupta JK
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal uterine bleeding on hormone replacement: the importance of intrauterine structural abnormalities.
    Akkad AA; Habiba MA; Ismail N; Abrams K; al-Azzawi F
    Obstet Gynecol; 1995 Sep; 86(3):330-4. PubMed ID: 7651636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of 42 cases of malignant endometrial polyps].
    Tang Z; Zhou R; Bao D; Liu C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):204-7. PubMed ID: 24820306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial polyps: symptomatology, menopausal status and malignancy.
    Golan A; Cohen-Sahar B; Keidar R; Condrea A; Ginath S; Sagiv R
    Gynecol Obstet Invest; 2010; 70(2):107-12. PubMed ID: 20332644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical polyps in postmenopausal women: is there a difference in risk?
    Schnatz PF; Ricci S; O'Sullivan DM
    Menopause; 2009; 16(3):524-8. PubMed ID: 19179926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
    Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
    J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy in endometrial polyps: a 12-year experience.
    Baiocchi G; Manci N; Pazzaglia M; Giannone L; Burnelli L; Giannone E; Fratini D; Di Renzo GC
    Am J Obstet Gynecol; 2009 Nov; 201(5):462.e1-4. PubMed ID: 19632664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
    Lubián López DM; Orihuela López F; García-Berbel Molina L; Boza Novo P; Pozuelo Solís E; Menor Almagro D; Comino Delgado R
    Gynecol Oncol; 2014 Apr; 133(1):56-62. PubMed ID: 24680592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps.
    Rahimi S; Marani C; Renzi C; Natale ME; Giovannini P; Zeloni R
    Int J Gynecol Pathol; 2009 Nov; 28(6):522-8. PubMed ID: 19851198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial polyps and associated factors in Danish women aged 36-74 years.
    Dreisler E; Sorensen SS; Lose G
    Am J Obstet Gynecol; 2009 Feb; 200(2):147.e1-6. PubMed ID: 18992861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women.
    Viola AS; Gouveia D; Andrade L; Aldrighi JM; Viola CF; Bahamondes L
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):207-13. PubMed ID: 18366497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.